The Lancet publishes final results from the first randomized controlled trial in Breast AI
PR Newswire —
New research highlights Transpara Detection's impact on the MASAI trial's final endpoint: interval cancers NIJMEGEN, Netherlands, Jan. 30, 2026 /PRNewswire/ -- ScreenPoint Medical, The Breast AI Company, highlights new research from Sweden's Mammography Screening with Artificial...